Cited by 595Liver physiology and pathologyLiver Disease Diagnosis and TreatmentLiver Disease and Transplantation

The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.

Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets

Open access

Zhang, Chong-Yang, Yuan, Wei-Gang, He, Pei, Lei, Jia-Hui, Wang, Chun-Xu·2016·World Journal of Gastroenterology

DOI 10.3748/wjg.v22.i48.10512PMC PMC5192262

Open this paper in CoChat — free account Open PDF

Abstract

Liver fibrosis is a reversible wound-healing process aimed at maintaining organ integrity, and presents as the critical pre-stage of liver cirrhosis, which will eventually progress to hepatocellular carcinoma in the absence of liver transplantation.Fibrosis generally results from chronic hepatic injury caused by various factors, mainly viral infection, schistosomiasis, and alcoholism; however, the exact pathological mechanisms are still unknown.Although numerous drugs have been shown to have antifibrotic activity in vitro and in animal models, none of these drugs have been shown to be efficacious in the clinic.Importantly, hepatic stellate cells (HSCs) play a key role in the initiation, progression, and regression of liver fibrosis by secreting fibrogenic factors that encourage portal fibrocytes, fibroblasts, and bone marrow-derived myofibroblasts to produce collagen and thereby propagate fibrosis.These cells are subject to intricate cross-talk with adjacent cells, resulting in scarring and subsequent liver damage.Thus, an understanding of the molecular mechanisms of liver fibrosis and their relationships with HSCs is essential for the discovery of new therapeutic targets.This comprehensive review outlines the role of HSCs in liver fibrosis and details novel strategies to suppress HSC activity, thereby providing new insights into potential treatments for liver fibrosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.3748/wjg.v22.i48.10512

Cites

112 of 112 references verified0 citation errors · 0 not checkable

Statistics

Figure 1 Initiation, progression, and resolution of liver fibrosis involving hepatic stellate cells. Upon various types of chronic injury - including that caused by alcohol, viral and schistosome infection, nonalcoholic steatohepatitis (NASH), and other factors - hepatic stellate cells (HSCs) transdifferentiate from quiescent HSCs to activated HSCs, the latter of which secrete abundant extracellular proteins that contribute to liver fibrosis. Liver fibrosis is thought to be a reversible condition owing to the elimination of causative agents and different strategies of limiting HSC activation; however, they cannot totally return to a quiescent status of the naive HSCs. Instead, they exhibit a pre-activated intermediate condition with an increased sensitivity to injury. Thus, preventing recurrent chronic liver injury is of great importance in patients undergoing treatment for liver fibrosis. Untreated or relapsed fibrosis progresses to liver cirrhosis, which often requires hepatic transplantation.CC BY-NC · PubMed Central

Figure 2 Roles of interleukin-30, hydrogen peroxide inducible clone 5, and cholesterol acyltransferase 1 in liver fibrosis.CC BY-NC · PubMed Central

Figure 3 Roles of the Wnt, TGF-β/Smad, and Gas6/Axl signaling pathways in the progression of liver fibrosis.CC BY-NC · PubMed Central

Figure 4 Mechanism of action of three potential therapeutic drugs-ursolic acid, 24-nor-ursodeoxycholic acid, and resveratrol-for treating fibrosis.CC BY-NC · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α
Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
Vernon, G. C., Baranova, A. V., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04724.x · Cited by 3,116
The burden of liver disease in Europe: A review of available epidemiological data
Blachier, M., Leleu, H., Peck‐Radosavljevic, M., Valla, D. C., & Roudot‐Thoraval, F. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.12.005 · Cited by 1,340
The natural history of nonalcoholic fatty liver: A follow-up study
Teli, M. R., James, O., Burt, A. D., Bennett, M. K., & Day, C. P. (1995) · Hepatology · doi:10.1002/hep.1840220616 · Cited by 913
Free fatty acids promote hepatic lipotoxicity by stimulating TNF-α expression via a lysosomal pathway
Feldstein, A. E., Werneburg, N. W., Canbay, A. E., Guicciardi, M. E., Bronk, S. F., Rydzewski, R. M., Burgart, L. J., & Gores, G. J. (2004) · Hepatology · doi:10.1002/hep.20283 · Cited by 851
CYP2E1 and oxidative liver injury by alcohol
Lu, Y., & Cederbaum, A. I. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.11.004 · Cited by 805
Hepatic fibrosis: concept to treatment
Trautwein, C., Friedman, S. L., Schuppan, D., & Pinzani, M. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.039 · Cited by 677
AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol
Um, J.-H., Park, S.-J., Kang, H., Yang, S., Foretz, M., McBurney, M. W., Kim, M. K., Viollet, B., & Chung, J. H. (2010) · Diabetes · doi:10.2337/db09-0482 · Cited by 647

Show all 112 references

Research works printed but not linked: 1

10.1002/cphy.c120035 · DOI · Paper page

Sorted by citations

Items 401–500 of 595

Mitigation of TGF-β/Smad signaling pathway-associated liver fibrosis by paeoniflorin
Li, W., & Wei, Z. (2017) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v16i9.9 · Cited by 5
Hepatic connective tissue growth factor expression and regulation differ between non-steatotic and non-alcoholic steatotic livers from brain-dead donor
Yang, D., Shi, J., Xia, Z., Guo, W.-Z., Ahmed, M. S., & Zhang, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-83516-2 · Cited by 5
Stem Cell Delivery Routes: From Preclinical Models to Clinical Applications
Fagoonee, S. (2021) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/97898150401041210101 · Cited by 5
MicroRNA-122-5p prevents proliferation and promotes apoptosis of hepatic stellate cells by suppressing the cellular-Abelsongene/histone deacetylases 2 pathway
Wu, Z., Wang, J., Feng, J.-Y., & Ying, L. (2022) · Human & Experimental Toxicology · doi:10.1177/09603271221084672 · Cited by 5
O -GlcNAcylation Coordinates Glutaminolysis by Regulating the Stability and Membrane Trafficking of ASCT2 in Hepatic Stellate Cells
Wang, F., Chen, L., Zhang, B., Li, Z., Shen, M., Li, T., Zhang, Z., Shao, J., Zhang, F., Zheng, S., et al. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2021.00413 · Cited by 5
Interleukin-6 Blockers Improve Inflammation-Induced Lipid Metabolism Impairments but Induce Liver Fibrosis in Collagen-Induced Arthritis
Denga, T. M., Gunter, S., Fourie, S., Roux, R. L., Manilall, A., Millen, A. M. E., & Mokotedi, L. P. (2022) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530323666221017153157 · Cited by 5
Circulating cell-free messenger RNA secretome characterization of primary sclerosing cholangitis
Chalasani, N., Vuppalanchi, R., Lammert, C. S., Gawrieh, S., Braun, J. V., Zhuang, J., Ibarra, A., Ross, D. A., Nerenberg, M. I., Quake, S. R., et al. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000140 · Cited by 6
Progress in the Correlation Between Inflammasome NLRP3 and Liver Fibrosis
Sun, M., Zhang, Y., Guo, A., Xia, Z., & Peng, L. (2023) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2023.00231 · Cited by 5
A Mendelian randomization study on the causal effects of cigarette smoking on liver fibrosis and cirrhosis
Guo, L., An, Y., Huang, X., Liu, W., Chen, F., Fan, Y., Gao, S., Han, L., & Wang, K. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1390049 · Cited by 5
Branched-chain amino acids and their metabolites decrease human and rat hepatic stellate cell activation
Almanza, M. C. T., Martínez-Aguilar, M., Buist‐Homan, M., Bömer, N., Gomez, K. F. A., de Meijer, V. E., van Vilsteren, F. G. I., Blokzijl, H., & Moshage, H. J. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-10027-4 · Cited by 7
ETP-specific-knockout mice reveal endotrophin as a key regulator of kidney fibrosis in ischemia–reperfusion injury models
Kim, D.-S., Funcke, J., Chen, S., Min, K., Onodera, T., Kim, M., Lin, Q., Joung, C., Velasco, J., Virostek, M., et al. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01567-1 · Cited by 6
Stellate cells in livers of dogs with portal vein hypoperfusion
Sobczak-Filipiak, M., Szarek, J., Czopowicz, M., Galanty, M., Dolka, I., Trębacz, P., Frymus, J., & Lechowski, R. (2018) · Medycyna Weterynaryjna · doi:10.21521/mw.6017 · Cited by 5
Gli3 is a novel downstream target of miR‑200a with an anti‑ﬁbrotic role for progression of liver fibrosis in�vivo and in�vitro
Li, L., Ran, J., Li, L., Chen, G., Zhang, S., & Wang, Y. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.10997 · Cited by 5
Interleukin-26 promotes the proliferation and activation of hepatic stellate cells to exacerbate liver fibrosis by the TGF-β1/Smad2 signaling pathway.
Zhang, X., Xie, X., Wang, Y., Li, W., & Lin, Z. (2019) · PubMed Central · Cited by 5
Molecular factors associated with regression of liver fibrosis of alcoholic etiology
Kiseleva, Y. V., Zharikov, Y. O., Maslennikov, R. V., Pavlov, C. S., & Nikolenko, V. N. (2021) · Terapevticheskii arkhiv · doi:10.26442/00403660.2021.02.200617 · Cited by 5
Antifibrotic Effects of Kangxian Ruangan Capsule on Rats with Nonalcoholic Fatty Liver Fibrosis and Hepatic Stellate Cells through Regulation of TGF-β and TLR4 Signaling Pathways
Liu, L., Zhou, Y., Dai, D., Xia, H., Zhao, K. F., & Zhang, J. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5649575 · Cited by 6
A CONVIVÊNCIA COM PESSOAS IDOSAS EM INSTITUIÇÕES DE ENSINO SUPERIOR: A PERCEPÇÃO DE ALUNOS DA GRADUAÇÃO E FUNCIONÁRIOS
Paula, R. D. S., Colares, F. C. D. J., de Toledo, J. O., & Nóbrega, O. D. T. (2010) · Americanae (AECID Library) · doi:10.23925/2176-901x.2008v11i1p%p · Cited by 5
Potential Role of Microfibrillar-Associated Protein 4, Fibrotic Indices and Oxidative Stress in Hepatocellular Carcinoma
Salama, M. M., Nomir, M., Fahmi, M. W., El-Gayar, A. M., & El‐Shishtawy, M. M. (2018) · Scientia Pharmaceutica · doi:10.3390/scipharm86040044 · Cited by 5
Transcriptional Profiling of Porcine HCC Xenografts Provides Insights Into Tumor Cell Microenvironment Signaling
Patel, S. S., Sandur, A., El-Kebir, M., Gaba, R. C., Schook, L. B., & Schachtschneider, K. M. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.657330 · Cited by 5
Phomopsterone B Alleviates Liver Fibrosis through mTOR-Mediated Autophagy and Apoptosis Pathway
Peng, M.-L., Zhang, L., Luo, Y., Xu, S.-Y., Long, X.-M., Ao, J.-L., Liao, S., Zhu, Q., He, X., & Xu, G. (2024) · Molecules · doi:10.3390/molecules29020417 · Cited by 4
Association between low-normal thyroid function and advanced liver fibrosis in metabolic dysfunction-associated fatty liver disease patients: a retrospective cohort study
Li, Z., Wu, X., Chen, Z., Wei, X., & Chen, W. (2023) · Gastroenterology report · doi:10.1093/gastro/goad076 · Cited by 4
Yangyinghuoxue decoction exerts a treatment effect on hepatic fibrosis by PI3K/AKT pathway in rat model: based on the network pharmacology and molecular docking
Bai, Y.-M., Liang, S., & Zhou, B. (2024) · Aging · doi:10.18632/aging.205559 · Cited by 4
The m6A reader IGF2BP1 contributes to the activation of hepatic stellate cells through facilitating TUBB4B mRNA stabilization
Li, Y., Chen, L., Li, S., Song, H., Chen, Y., & Wang, S. (2024) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16765 · Cited by 4
The transcription factor mesenchyme homeobox 1 exacerbates hepatic fibrosis by transcriptional activation of connective tissue growth factor
Jiao, X., Lai, L., Bo, S., Qian, Y., & Yang, W. (2025) · Experimental Cell Research · doi:10.1016/j.yexcr.2025.114513 · Cited by 4
VitroBert: modeling DILI by pretraining BERT on in vitro data
Masood, M. A., Nagaraja, A. A., Belaid, K., Mesens, N., Ceulemans, H., Samuel Kaski, A., Herman, D., & Heinonen, M. (2025) · Journal of Cheminformatics · doi:10.1186/s13321-025-01048-7 · Cited by 4
Cell type heterogeneity in gene co-expression networks: implications for toxicological research
Bruns, I. B., Li, Y., Stevens, J. L., van de Water, B., & Callegaro, G. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf421 · Cited by 5
Development and clinical validation of a novel protein biomarkers-based algorithm for risk prediction and diagnosis of advanced liver fibrosis: a multi-centre study
Cheung, C. Y. Y., Wan, P., Wan, H., Xu, C., Jia, X., Fong, C. H.-Y., Lui, D. T. W., Song, E., Chen, X., Chow, W.-S., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.09.033 · Cited by 4
Self-citation
Cationic PPC liposomes with dual targeting modules for enhanced liver fibrosis therapy via the extracellular matrix barrier
Li, Y., Zhou, Y., Wu, L., Gao, Q., & Wang, W. (2025) · Biomaterials Science · doi:10.1039/d5bm01262g · Cited by 5
CAT1 modulates hepatic fibrosis via IL-6-mediated inflammatory and fibrogenic pathways in hepatic stellate cells
Deng, X., Li, Z., Xu, Z., & Peng, F. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2025.120075 · Cited by 4
Pathogenesis, diagnosis and management of chronic hepatitis B related liver fibrosis
Kösekli, M. A., & Aktaş, G. (2025) · Minerva Gastroenterology · doi:10.23736/s2724-5985.25.03862-8 · Cited by 4
Inhibiting HSCs Activation and Ameliorating Alcoholic Liver Fibrosis by Fucoidan Targeting the TLR4/NF‐κB Pathway
Wang, G., Zhang, N., Zhou, Y., Yan, J., Liu, Y., Liu, M., Xue, M., & Liang, H. W. (2025) · Journal of Food Science · doi:10.1111/1750-3841.70682 · Cited by 4
Expression of fibrosis‐related genes in liver allografts: Association with histology and long‐term outcome after pediatric liver transplantation
Voutilainen, S. H., Kosola, S. K., Lohi, J., Jahnukainen, T., Pakarinen, M. P., & Jalanko, H. (2021) · Clinical Transplantation · doi:10.1111/ctr.14373 · Cited by 4
Contextualization of causal regulatory networks from toxicogenomics data applied to drug-induced liver injury
Trairatphisan, P., de Souza, T. M., Kleinjans, J. C. S., Jennen, D. G. J., & Sáez-Rodríguez, J. (2021) · Toxicology Letters · doi:10.1016/j.toxlet.2021.06.020 · Cited by 4
Effect of Quercetin on the Expression of NOXs and P-Smad3C in TGF-Β-Activated Hepatic Stellate Cell Line LX-2
Mohammadtaghvaei, N., Afarin, R., Mavalizadeh, F., Shakerian, E., Bavarsad, S. S., & Mohammadzadeh, G. (2021) · Hepatitis Monthly · doi:10.5812/hepatmon.116875 · Cited by 4
Simultaneous liver steatosis, fibrosis and iron deposition quantification with mDixon quant based on radiomics analysis in a rabbit model
Liqiu, Z., Zhang, H., Wang, Q., Zhong, W., Du, Y., Liu, H., & Xing, W. (2022) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2022.08.013 · Cited by 4
Sodium-glucose cotransporter 2 inhibitors ameliorate ER stress-induced pro-inflammatory cytokine expression by inhibiting CD36 in NAFLD progression in vitro
Lee, J., Hong, S., Kim, M.-J., Lim, Y.-M., Moon, S. J., Kwon, H., Park, S. E., Rhee, E., & Lee, W. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150620 · Cited by 4
Hidden Hunger: A Forgotten Comorbidity of Metabolic‐Syndrome‐Associated Fatty Liver Disease
Agu, P. C., & Lu, J. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70134 · Cited by 4
Effectiveness of vinpocetine and isosorbide-5-mononitrate on experimental schistosomiasis mansoni: Biochemical and immunohistochemical study
Alhusseiny, S. M., El-Beshbishi, S. N., Hashim, M. M. A., El-nemr, H. E.-D. E., & Handoussa, A. E. (2018) · Acta Tropica · doi:10.1016/j.actatropica.2018.06.010 · Cited by 4
Liver fibrosis mechanisms – the role of stellate cells, oxidative and nitrosative stress
Czechowska, G., Celiński, K., & Wójcicka, G. (2019) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/01.3001.0013.1974 · Cited by 4
4-Methoxy Sulfonyl Paeonol Inhibits Hepatic Stellate Cell Activation and Liver Fibrosis by Blocking the TGF-β1/Smad, PDGF-BB/MAPK and Akt Signaling Pathways
Liao, Y., Wang, Y.-H., Liu, C.-L., Fang, C.-C., Hsu, M.-H., & Suk, F. (2020) · Applied Sciences · doi:10.3390/app10175941 · Cited by 4
Synthesis and biological evaluation of fluorinated 3,4- dihydroquinolin-2(1 H )-ones and 2-oxindoles for anti-hepatic fibrosis
Li, M., He, F., Ji, L., Gao, Y., Zhang, X., Yu, Z., Fang, M., Wu, J., & Gao, Y. (2021) · RSC Advances · doi:10.1039/d0ra09430g · Cited by 4
Advances on Nanomedicines for Diagnosis and Theranostics of Hepatic Fibrosis
Dai, X., Zeng, Y., Zhang, H., Gu, Z., Gong, Q., & Luo, K. (2021) · Advanced NanoBiomed Research · doi:10.1002/anbr.202000091 · Cited by 4
Effect of Mercuric Chloride Exposure during Pregnancy and Lactation on the Postnatal Development of the Liver in the Albino Rat
Mohamed, M., El-Meligy, M., Bushra, R., & Mohamed, E. (2019) · The Egyptian Journal of Anatomy · doi:10.21608/ejana.2019.251310 · Cited by 4
MicroRNA-181b promotes schistosomiasis-induced hepatic fibrosis by targeting Smad7
Wang, S., Zhang, J., Chen, H., Zhan, X., Nie, H., Wang, C., Zhang, Y., Zheng, B., & Gong, Q. (2022) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2022.111523 · Cited by 4
Self-citation
Phytochemical Profiling and Anti-Fibrotic Activities of the Gemmotherapy Bud Extract of Corylus avellana in a Model of Liver Fibrosis on Diabetic Mice
Baltă, C., Herman, H., Ciceu, A., Mladin, B., Roșu, M., Sasu, A., Peteu, V. E., Voicu, S. N., Balaș, M., Gherghiceanu, M., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11061771 · Cited by 4
Application Value of Magnetic Resonance Perfusion Imaging in the Early Diagnosis of Rat Hepatic Fibrosis
Fan, G., Ya, Y., Ni, X., Hou, J., & Yu, R. (2019) · BioMed Research International · doi:10.1155/2019/5095934 · Cited by 4
Study on the effect of Mongolian medicine Qiwei Qinggan Powder on hepatic fibrosis through JAK2/STAT3 pathway
Liang, J., Yuan, H., Xu, L., Wang, F., Bao, X., Yan, Y., Wang, H., Zhang, C., Jin, R., Ma, L., et al. (2021) · Bioscience Biotechnology and Biochemistry · doi:10.1093/bbb/zbab001 · Cited by 4
Self-citation
Integrated analysis of differentially expressed genes, differentially methylated genes, and natural compounds in hepatitis C virus-induced cirrhosis
Cheng, J., Chen, Z., Zuo, G., & Cao, W. (2022) · Journal of International Medical Research · doi:10.1177/03000605221074525 · Cited by 4
Extracellular Vesicle-Associated Neutrophil Elastase Activates Hepatic Stellate Cells and Promotes Liver Fibrogenesis via ERK1/2 PathwayPreprint
Oshins, R. A., Greenberg, Z., Tai, Y., Zhao, D., Wang, X., Mehrad, B., He, M., Patel, I. J., Khartabil, L., Zhou, H., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.20.608832 · Cited by 4
Protective Effects of COG133 on Carbon Tetrachloride‐Induced Acute Liver Injury: Modulation of Inflammation, Apoptosis and Sphingolipid Metabolism
Aslan, M., Çırçırlı, B., Öztüzün, A., Tuzcu, H., Yılmaz, Ç., Çeker, T., & Elpek, G. Ö. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70677 · Cited by 3
1,2-bis(2,4,6-tribromophenoxy) ethane, a novel brominated flame retardant, induces hepatic fibrosis: New insights into crosstalk between macrophage extracellular traps and stellate cell activation
Cui, Y., Wang, Z., Zhang, Q., Yang, J., Liu, Y., Wang, Y., Zhang, H., Chen, L., Hao, W., Jiang, J., et al. (2025) · Environmental Research · doi:10.1016/j.envres.2025.123278 · Cited by 3
Hepatic stellate cells shape the ECM-disorganized and immunosuppressive microenvironment via CCL11/CCR3 axis in lenvatinib-treated hepatocellular carcinoma
Qiang, N., Cheng, L., An, L. K., Kanzaki, H., Inoue, M., Kanogawa, N., Kondo, T., Ogasawara, S., Nakamura, M. R., Nakamoto, S., et al. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.112263 · Cited by 3
Preclinical research of dihydromyricetin for fibrotic diseases
Wang, X., Mai, P., Yuan, Z.-H., & Qiu, Z. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1691796 · Cited by 3
Identification of differentially expressed long noncoding RNAs and pathways in liver tissues from rats with hepatic fibrosis
Wang, Y., Xiao, X., Wang, X., Guo, F., & Wang, X. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258194 · Cited by 3
Deleterious liver-adipose crosstalk in obesity: Hydroethanolic extract of Lampaya medicinalis Phil. (Verbenaceae) counteracts fatty acid-induced fibrotic marker expression in human hepatocytes
Yuri, G., Sanhueza, S., Paredes, A., Morales, G., Cifuentes, M., & Ormazabal, P. (2023) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2023.111882 · Cited by 3
The protective effects of Ninjin’yoeito against liver steatosis/fibrosis in a non-alcoholic steatohepatitis model mouse
Takano, K., Kaneda, M., Aoki, Y., Fujita, N., Chiba, S., Michihara, S., Han, L., & Takahashi, R. (2024) · Journal of Natural Medicines · doi:10.1007/s11418-024-01786-2 · Cited by 3
Single-Cell Sequencing Reveals the Heterogeneity of Hepatic Natural Killer Cells and Identifies the Cytotoxic Natural Killer Subset in Schistosomiasis Mice
Xu, F., Gao, Y., Li, T., Jiang, T., Wu, X., Yu, Z., Zhang, J., Hu, Y., & Cao, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073211 · Cited by 3
Hepatic-stellate-cell-targeted delivery of PU.1 decoy ODN by Apt-Tan attenuates liver fibrosis in mice
Tan, Y., Zhang, L.-Y., Sun, Y. L., Luo, X., Wu, S., Wu, X., Zhang, Y., Wang, Y., Li, B.-T., Ni, Y., et al. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102607 · Cited by 3
Resveratrol reduces radiation-induced liver damage and fibrosis, and may be related to inhibiting cellular aging and reducing inflammation
Zhai, S., Xu, H., Xue, J., Gan, L., Gao, F., & Hu, L. (2025) · Innate Immunity · doi:10.1177/17534259251352623 · Cited by 3
The immunopathogenesis of fibrosis
Ihnatovich, T., & Zafranskaya, M. M. (2019) · Immunopathology Allergology Infectology · doi:10.14427/jipai.2019.1.6 · Cited by 3
Bioengineered 3D electrospun nanofibrous scaffold with human liver cells to study alcoholic liver disease in vitro.
Das, P., DiVito, M. D., Wertheim, J. A., & Tan, L. P. (2021) · PubMed · doi:10.1093/intbio/zyab011 · Cited by 4
Evaluate the effect of licorice on anti-liver fibrosis: a systematic review and meta-analysis
Li-Ping, C. H. E. N., Wu, X., ZHANG, Z.-L., Ling, W. A. N. G., ZHANG, F., Zheng, S., & Kong, D.-S. (2022) · Food Science and Technology · doi:10.1590/fst.103321 · Cited by 3
Protective Mechanism of Nostoc sphaeroides Kütz. Polysaccharide on Liver Fibrosis by HFD-Induced Liver Fat Synthesis and Oxidative Stress
Yang, L., & Zhang, B. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/1745244 · Cited by 3
Baseline serum Mac-2 binding protein glycosylation isomer as a predictor of hepatocellular carcinoma in chronic hepatitis B patients: a systematic review and meta-analysis
Witarto, A. P. (2022) · Annals of Gastroenterology · doi:10.20524/aog.2022.0751 · Cited by 3
The Ultrastructure of Hepatic Stellate Cell–Macrophage Intercellular Crosstalk as a New Morphological Insight into Phenomenon of Fibrogenesis in Pediatric Autoimmune Hepatitis
Łotowska, J. M., Sobaniec-Lotowska, M. E., Bobrus‐Chociej, A., & Sobaniec, P. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12031024 · Cited by 3
A Hierarchical Siamese Network for Noninvasive Staging of Liver Fibrosis Based on US Image Pairs of the Liver and Spleen
Wang, X., Song, L., Zhuang, Y., Han, L., Chen, K., Lin, J., & Luo, Y. (2023) · Sensors · doi:10.3390/s23125450 · Cited by 3
Proteome deconvolution of liver biopsies reveals hepatic cell composition as an important marker of fibrosis
Handin, N., Yuan, D., Ölander, M., Wegler, C., Karlsson, C., Jansson‐Löfmark, R., Hjelmesaeth, J. S., Åsberg, A., Lauschke, V. M., & Artursson, P. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.08.037 · Cited by 3
Human hepatocytes response to pathological shifts in liver fibrosis
Chrysanthus, C. S. (2024) · The Journal of Medical Research · doi:10.31254/jmr.2024.10108 · Cited by 3
Chondroitin Sulfate-Based Imatinib Nanoparticles Targeting Activated Hepatic Stellate Cells Against Hepatic Fibrosis
Liu, X., Fang, C., Yu, H., Huang, L., Feng, J., Luo, S., Li, S., Wu, M., Tan, Y., Dong, J., et al. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17030351 · Cited by 3
Molecular aspects of alcoholic liver fibr
Kiseleva, Y. V., Zharikov, Y., Maslennikov, R. V., Pavlov, C. S., & Nikolenko, V. N. (2020) · Medical news of the North Caucasus · doi:10.14300/mnnc.2020.15070 · Cited by 3
Liver pathology and biochemistry in patients with mutations in TRIM37 gene (Mulibrey nanism)
Sivunen, J., Karlberg, S., Kivisaari, R., Lohi, J., Karlberg, N., Jokinen, E. V., Sarkola, T., Jahnukainen, T., Lipsanen‐Nyman, M., & Jalanko, H. (2022) · Liver International · doi:10.1111/liv.15213 · Cited by 3
Protective effects of dopamine against non-alcoholic steatohepatitis via inhibiting p65 pathways in vivo and in vitro
Ma, P., Wang, X., Wen, X., Pu, L., & Ou, Y. (2024) · Toxicology Research · doi:10.1093/toxres/tfae068 · Cited by 2
The Biological Effects and Mechanisms of Fisetin on Hepatotoxicity, Liver Injury and Liver Fibrosis: A Systematic Review
Rahimian, G., Heidari-Soureshjani, S., & Kasiri, K. (2024) · The Natural Products Journal · doi:10.2174/0122103155333233240906193500 · Cited by 3
Aldose Reductase -Mediated HUR Ubiquitination Enhances Exosome Release and Hepatic Fibrosis via ROS/PI3K/AKT Pathway.
Wang, J.-F., Shi, K., Xu, Q., Wang, H.-W., Wang, Y.-R., Liu, S.-C., Jiang, W.-J., Chen, R., Chen, Y., Zhang, Y.-D., et al. (2025) · Free Radical Biology & Medicine · doi:10.1016/j.freeradbiomed.2025.04.045 · Cited by 3
Identification of Key Gene Related to Matrisome in HBV‐Associated Liver Cirrhosis via Bioinformatics Analysis
Chaulagain, R. P., Shrestha, Y., Dinislam, K., & Jin, S. (2025) · International Journal of Hepatology · doi:10.1155/ijh/5532643 · Cited by 2
Reframing fibrosis as a barrier to regeneration and gene delivery in muscular diseases
Kılıç, H. B., & Kocaefe, Ç. (2026) · FEBS Journal · doi:10.1111/febs.70427 · Cited by 3
Recent updates on engineered nanomedicines for treatment of fibrosis
Ziada, A. R., Xin, C., & Elzoghby, A. O. (2026) · Nanomedicine · doi:10.1080/17435889.2026.2628236 · Cited by 2
Pesticides Drive Liver Diseases Through Non-Apoptotic Regulated Cell Death Pathways
Khairullina, Z. S., Kurmangaliyeva, S. S., Yussupov, R., Kelimberdiyeva, E., Tryfonyuk, L., Shapambayev, N., Seidakhmetova, A., Medetbekov, T., & Tkachenko, A. (2026) · Diseases · doi:10.3390/diseases14030096 · Cited by 3
Toll of Chronic Metabolic Acidosis at Molecular, Cellular, and Systemic Levels: A Conceptual Framework to Revisit Type 2 Diabetes (T2D) Pathophysiology
Sater, M. S., & Giha, H. A. (2026) · Biomedicines · doi:10.3390/biomedicines14040901 · Cited by 2
Effect of long non‑coding RNA AK021443 on promoting hepatic fibrosis in vitro
Yang, Y., & Min, Z. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.11835 · Cited by 2
Three new feruloyl glucuronopyranosyl glycerols from Eriocaulon buergerianum with their anti-fibrotic effects on hepatic stellate cells
Zhang, Y., Li, H., Xu, Z., Shi, Y., Li, B., Li, J., Aisa, H. A., Zang, Y., & Zhu, W. (2022) · Natural Product Research · doi:10.1080/14786419.2022.2099387 · Cited by 2
[Role of hyperglycemia-induced 5-hydroxytryptamine degradation of hepatic stellate cells in hepatic inflammation and fibrosis induced by type 2 diabetes mellitus].
Liang, X., Shan, X., Guan, J., Zhang, R., Yang, J., Zhang, Y., jin, J., Zhang, Y., Xu, F., & Fu, J. (2022) · PubMed Central · doi:10.19723/j.issn.1671-167x.2022.06.014 · Cited by 2
Serological indices and ultrasound variables in predicting the staging of hepatitis B liver fibrosis: A comparative study based on random forest algorithm and traditional methods
Xie, D., Ying, M., Lian, J., Li, X., Liu, F., Yu, X., & Ni, C. (2022) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_1394_22 · Cited by 2
Elastic modulus-reflected liver lesion stiffness relates to worse prognosis in pancreatic cancer patients with liver metastasis
Dong, S., Miao, X., Zhang, K., Zhu, X., Gao, Y., & Chen, H. (2023) · World Journal of Surgical Oncology · doi:10.1186/s12957-023-03140-4 · Cited by 2
[Arbutin ameliorates liver fibrosis in mice by inhibiting macrophage recruitment and regulating the Akt/NF-κB and Smad signaling pathways].
Cao, J., Sun, Y., Ding, X., Li, S., Chen, B., & Lan, T. (2024) · PubMed Central · doi:10.12122/j.issn.1673-4254.2024.04.05 · Cited by 2
Discovery of Fluorescent Probe ABDS-2 for Farnesoid X Receptor Modulator Characterization and Cell-Based Imaging
Qiu, X., Li, W., Li, X., Wu, B., Dai, M., Xia, Y., Zhang, G., Bian, Y., Chen, J., Wu, K., et al. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.4c03743 · Cited by 2
Circ_0098181 binds PKM2 to attenuate liver fibrosis
Luo, Y., Guan, Y., Zhan, H.-F., Sun, C.-Y., Cai, L.-Y., Tao, K.-G., Lin, Y., & Zeng, X. Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1517250 · Cited by 2
Metabolomic profiling for identification of metabolites and relevant pathways for taurine in hepatic stellate cells
Deng, X., Liang, X.-Q., Lu, F.-G., Zhao, X., Fu, L., & Liang, J. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i31.5713 · Cited by 2
Clinical and immunomorphological predictors of the adverse course of chronic hepatitis C
Karabak, I. A., Lobzin, D. Y., & Karev, V. E. (2020) · Journal Infectology · doi:10.22625/2072-6732-2020-12-2-79-87 · Cited by 2
Effect of oligoribonucleotides with D-mannitol complexes on oxidative stress indicators against thioacetamide-induced liver fibrosis
Marchyshak, T., Yakovenko, T., & Tkachuk, Z. Y. (2020) · ScienceRise Biological Science · doi:10.15587/2519-8025.2020.214418 · Cited by 2
Ultrasound Image Computerized Analysis for Non-invasive Quantitative Evaluation of Hepatic Fibrosis
Nagy, G. A., Neag, M. A., Gordan, M. L., Crişan, D., Mircea, P. A., & Chira, R. I. (2021) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2021.20951 · Cited by 2
The Promising Role of Anti-Fibrotic Agent Halofuginone in Liver Fibrosis/Cirrhosis
Karakoyun, B. (2017) · InTech eBooks · doi:10.5772/intechopen.68641 · Cited by 2
Ileal interposition surgery targets the hepatic TGF‐β pathway, influencing gluconeogenesis and mitochondrial bioenergetics in the UCD‐T2DM rat model of diabetes
Hung, C., Napoli, E., Ross‐Inta, C., Graham, J. L., Flores, A., Stanhope, K. L., Froment, P., Havel, P. J., & Giulivi, C. (2019) · The FASEB Journal · doi:10.1096/fj.201802714r · Cited by 2
Characterization of Pro-Fibrotic Signaling Pathways using Human Hepatic OrganoidsPreprint
Guan, Y., Fang, Z., Hu, A., Roberts, S., Wang, M., Ren, W., Johansson, P. K., Heilshorn, S. C., Enejder, A. M. K., & Peltz, G. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.25.538102 · Cited by 2
Cytoskeleton Remodeling-Related Proteins Represent a Specific Salivary Signature in PSC Patients
Ceccherini, E., Morlando, A., Norelli, F., Coco, B. A., Bellini, M., Brunetto, M. R., Cecchettini, A., & Rocchiccioli, S. (2024) · Molecules · doi:10.3390/molecules29235783 · Cited by 1
Exploring the molecular mechanisms through which overexpression of TET3 alleviates liver fibrosis in mice via ferroptosis in hepatic stellate cells
Liu, Y., Feng, L., Han, B., Cai, L.-J., Liu, R.-Y., Tang, S., & Yang, Q. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.111747 · Cited by 1
Tudor staphylococcal nuclease (Tudor‐ SN ) regulates activation of quiescent hepatic stellate cells
Qian, B., Zhao, Y., Zhang, X., Zhao, C., Cui, X., Wang, F., Jing, X., Ge, L., Yao, Z., Gao, X., et al. (2025) · FEBS Journal · doi:10.1111/febs.70073 · Cited by 1
cPLA2α on the influence of Th17 and its role in the formation of liver fibrosis
Ma, L., Wang, W., Gu, L., & Wang, L. (2025) · Cytotechnology · doi:10.1007/s10616-025-00750-6 · Cited by 1
Therapeutic approaches for liver fibrosis/cirrhosis by targeting pyroptosis
Qiao, G., Li, P., Wang, M., Li, C., Wang, Y., Xin, S., & Liu, H. (2025) · Open Life Sciences · doi:10.1515/biol-2025-1092 · Cited by 2
Growth differentiation factor-15 as a non-invasive biomarker of liver fibrosis in sickle cell disease
Manganas, K., Delicou, S., Hadziyannis, E. S., Giannouli, S., & Koskinas, J. S. (2025) · International Journal of Hematology · doi:10.1007/s12185-025-04035-8 · Cited by 1

Authors: Zhang, C.-Y., Yuan, W.-G., He, P., Lei, J.-H., & Wang, C.-X.
Affiliations: Huazhong University of Science and Technology (CN)
Venue: World Journal of Gastroenterology
Publisher: Baishideng Publishing Group Inc.
Published: 2016
Volume: 22
Issue: 48
Pages: 10512
ISSN: 1007-9327 (ISSN-L)
DOI: 10.3748/wjg.v22.i48.10512
PMC: PMC5192262
OpenAlex: W2565367159
Cited by: 594
References: 112
Citations by year: 2026: 37 · 2025: 70 · 2024: 75 · 2023: 80 · 2022: 84 · 2021: 88 · 2020: 60 · 2019: 59 · 2018: 24 · 2017: 15
FWCI: 4.07
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc
Locations: World Journal of Gastroenterology (publishedVersion, cc-by-nc)
Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
PubMed Central (publishedVersion, cc-by-nc)
PubMed (publishedVersion)
Funders: National Natural Science Foundation of China (81300251)
Topics: Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Keywords: liver fibrosis, hepatic stellate cells, liver cirrhosis, hepatocellular carcinoma, antifibrotic therapy, fibrogenic factors, collagen synthesis, myofibroblasts, viral hepatitis, schistosomiasis, alcoholic liver disease, cell-cell crosstalk, therapeutic target
MeSH terms: Resveratrol, Ursolic Acid, Acetyl-CoA C-Acetyltransferase, Animals, Fatty Liver, Alcoholic, Humans, Interleukins, Liver Cirrhosis, Macrophages, Schistosomiasis, Stilbenes, Triterpenes, Ursodeoxycholic Acid, Virus Diseases, Signal Transduction, CD4-Positive T-Lymphocytes, Disease Progression, MicroRNAs, Intracellular Signaling Peptides and Proteins, T-Lymphocytes, Regulatory, Hepatic Stellate Cells, Molecular Targeted Therapy, LIM Domain Proteins, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks